IDEXX LABORATORIES INC
corporate_fare Company Profile
IDEXX LABORATORIES INC (NASDAQ:IDXX) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 14 items for IDXX at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-09-16, rated 7/10. Across its 14 most recent items scored 7 or higher, the top rating is 8/10, with 9 rated 8 or above. Recent SEC coverage for IDXX spans 10-Q, 8-K, DEFA14A, DEF 14A.
Recent high-impact activity:
- IDEXX Acquires CoVetAI to Boost Veterinary Workflow Intelligence
- IDEXX Raises 2026 EPS Guidance to $14.69-$14.94 After Strong Q2 Beat
- IDEXX Reports Strong Q2 Results, Raises Full-Year Revenue and EPS Guidance
- IDEXX Raises 2026 EPS Guidance to $14.69-$14.94 on Strong Q2
- Shareholders Approve Board Declassification and Special Meeting Rights
Financial Snapshot
Short Interest & Short Volume
3.77 days to coverFINRA reported short interest of 1,917,016 shares in IDXX as of the September 15, 2026 settlement, a 8.4% decrease from the prior period — about 3.8 days to cover at its recent average daily volume. On October 2, 2026, 59.4% of IDXX volume reported to FINRA trade-reporting facilities was marked short.
Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.